James Sapirstein, Chief Executive Officer at ContraVir Pharmaceuticals, Inc. (CTRV), bought 10,000 shares at $1.00 ($10K) on 2016-02-18, disclosed to the SEC on 2016-02-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| FWBI | SELL | 2024-03-19 | $9K | — | Filing → |
| FWBI | SELL | 2024-01-17 | $697 | — | Filing → |
| FWBI | SELL | 2023-10-06 | $802 | — | Filing → |